Lindbrook Capital, LLC Neurocrine Biosciences Inc Transaction History

Lindbrook Capital, LLC

$1.06 Billion
Q1 2025

A detailed history of Lindbrook Capital, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 483 shares of NBIX stock, worth $58,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares

483

Previous 373 29.49%

Holding current value

$58,046

Previous $50,000 6.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$107.22 - $153.29 $11,794 - $16,861	110 Added 29.49%	483 $53,000
Q4 2024 Feb 06, 2025	BUY	$111.62 - $139.44 $14,510 - $18,127	130 Added 53.5%	373 $50,000
Q3 2024 Nov 01, 2024	BUY	$114.58 - $153.15 $1,947 - $2,603	17 Added 7.52%	243 $27,000
Q2 2024 Jul 31, 2024	BUY	$130.86 - $143.19 $1,046 - $1,145	8 Added 3.67%	226 $31,000
Q1 2024 Apr 25, 2024	BUY	$130.4 - $143.74 $1,173 - $1,293	9 Added 4.31%	218 $30,000
Q4 2023 Jan 31, 2024	BUY	$106.07 - $132.76 $10,182 - $12,744	96 Added 84.96%	209 $27,000
Q3 2023 Oct 25, 2023	BUY	$94.02 - $117.1 $5,547 - $6,908	59 Added 109.26%	113 $12,000
Q2 2023 Jul 28, 2023	SELL	$89.53 - $104.87 $447 - $524	-5 Reduced 8.47%	54 $5,000
Q1 2023 Apr 26, 2023	SELL	$94.11 - $123.02 $5,458 - $7,135	-58 Reduced 49.57%	59 $5,000
Q4 2022 Jan 24, 2023	BUY	$106.72 - $127.06 $2,988 - $3,557	28 Added 31.46%	117 $0
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $3,589 - $4,204	39 Added 78.0%	89 $9,000
Q2 2022 Aug 01, 2022	BUY	$75.79 - $100.07 $303 - $400	4 Added 8.7%	50 $5,000
Q1 2022 Apr 21, 2022	SELL	$72.45 - $94.81 $3,042 - $3,982	-42 Reduced 47.73%	46 $4,000
Q4 2021 Jan 18, 2022	SELL	$79.65 - $106.22 $1,672 - $2,230	-21 Reduced 19.27%	88 $7,000
Q2 2021 Jul 27, 2021	SELL	$89.43 - $102.27 $804 - $920	-9 Reduced 7.63%	109 $11,000
Q4 2020 Jan 27, 2021	BUY	$86.91 - $108.33 $956 - $1,191	11 Added 10.28%	118 $11,000
Q3 2020 Nov 03, 2020	BUY	$96.16 - $135.15 $961 - $1,351	10 Added 10.31%	107 $10,000
Q2 2020 Jul 27, 2020	SELL	$85.09 - $130.36 $1,616 - $2,476	-19 Reduced 16.38%	97 $12,000
Q1 2020 Apr 22, 2020	BUY	$75.11 - $113.76 $75 - $113	1 Added 0.87%	116 $10,000
Q3 2019 Oct 31, 2019	BUY	$83.82 - $101.5 $1,508 - $1,827	18 Added 18.56%	115 $10,000
Q4 2018 Feb 07, 2019	BUY	$68.32 - $124.36 $6,627 - $12,062	97 New	97 $6,000

Others Institutions Holding NBIX

# of Institutions

650

Shares Held

97.2M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Neurocrine Biosciences Inc Transaction History